These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 33150133)

  • 1. Comparative Effectiveness of Reperfusion Strategies in Patients with ST-Segment Elevation Myocardial Infarction: A Secondary Analysis of the Acute Coronary Syndrome Quality Improvement in Kerala (ACS QUIK) Trial.
    Khraishah H; Alahmad B; Secemsky E; Young MN; ElGuindy A; Siedner MJ; Kassab M; Kholte D; Khanbhai K; Janabi M; Kennedy K; Albaghdadi MS
    Glob Heart; 2020 Oct; 15(1):68. PubMed ID: 33150133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and Safety of a Pharmaco-Invasive Strategy With Half-Dose Alteplase Versus Primary Angioplasty in ST-Segment-Elevation Myocardial Infarction: EARLY-MYO Trial (Early Routine Catheterization After Alteplase Fibrinolysis Versus Primary PCI in Acute ST-Segment-Elevation Myocardial Infarction).
    Pu J; Ding S; Ge H; Han Y; Guo J; Lin R; Su X; Zhang H; Chen L; He B;
    Circulation; 2017 Oct; 136(16):1462-1473. PubMed ID: 28844990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temporal Trends in Care and Outcomes of Patients Receiving Fibrinolytic Therapy Compared to Primary Percutaneous Coronary Intervention: Insights From the Get With The Guidelines Coronary Artery Disease (GWTG-CAD) Registry.
    Hira RS; Bhatt DL; Fonarow GC; Heidenreich PA; Ju C; Virani SS; Bozkurt B; Petersen LA; Hernandez AF; Schwamm LH; Eapen ZJ; Albert MA; Liang L; Matsouaka RA; Peterson ED; Jneid H
    J Am Heart Assoc; 2016 Oct; 5(10):. PubMed ID: 27792640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacoinvasive Strategy Versus Primary Percutaneous Coronary Intervention in Patients With ST-Segment-Elevation Myocardial Infarction: A Propensity Score-Matched Analysis.
    Sim DS; Jeong MH; Ahn Y; Kim YJ; Chae SC; Hong TJ; Seong IW; Chae JK; Kim CJ; Cho MC; Rha SW; Bae JH; Seung KB; Park SJ;
    Circ Cardiovasc Interv; 2016 Sep; 9(9):. PubMed ID: 27582112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal Trends of Reperfusion Strategies and Hospital Mortality for Patients With STEMI in Percutaneous Coronary Intervention-Capable Hospitals.
    Tran DT; Welsh RC; Ohinmaa A; Thanh NX; Kaul P
    Can J Cardiol; 2017 Apr; 33(4):485-492. PubMed ID: 28256426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacoinvasive and Primary Percutaneous Coronary Intervention Strategies in ST-Elevation Myocardial Infarction (from the Mayo Clinic STEMI Network).
    Siontis KC; Barsness GW; Lennon RJ; Holmen JL; Wright RS; Bell MR; Gersh BJ
    Am J Cardiol; 2016 Jun; 117(12):1904-10. PubMed ID: 27131614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Comparison of the Outcomes between Primary PCI, Fibrinolysis, and No Reperfusion in Patients ≥ 75 Years Old with ST-Segment Elevation Myocardial Infarction: Results from the Chinese Acute Myocardial Infarction (CAMI) Registry.
    Peiyuan H; Jingang Y; Haiyan X; Xiaojin G; Ying X; Yuan W; Wei L; Yang W; Xinran T; Ruohua Y; Chen J; Lei S; Xuan Z; Rui F; Yunqing Y; Qiuting D; Hui S; Xinxin Y; Runlin G; Yuejin Y;
    PLoS One; 2016; 11(11):e0165672. PubMed ID: 27812152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of the shift to a fibrinolysis-first strategy on care and outcomes of patients with ST-segment-elevation myocardial infarction during the COVID-19 pandemic-The experience from the largest cardiovascular-specific centre in China.
    Leng WX; Yang JG; Li XD; Jiang WY; Gao LJ; Wu Y; Yang YM; Yuan JQ; Yang WX; Qiao SB; Yang YJ
    Int J Cardiol; 2021 Apr; 329():260-265. PubMed ID: 33307137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics, treatment and in-hospital outcomes of patients with STEMI in a metropolitan area of a developing country: an initial report of the extended Jakarta Acute Coronary Syndrome registry.
    Dharma S; Andriantoro H; Purnawan I; Dakota I; Basalamah F; Hartono B; Rasmin R; Isnanijah H; Yamin M; Wijaya IP; Pratama V; Gunarto TB; Juwana YB; Suling FR; Witjaksono AM; Lasanudin HF; Iskandarsyah K; Priatna H; Tedjasukmana P; Wahyumandradi U; Kosasih A; Budhiarti IA; Pribadi W; Wirianta J; Lubiantoro U; Pramesti R; Widowati DR; Aminda SK; Basalamah MA; Rao SV
    BMJ Open; 2016 Aug; 6(8):e012193. PubMed ID: 27580835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship Between Arterial Access and Outcomes in ST-Elevation Myocardial Infarction With a Pharmacoinvasive Versus Primary Percutaneous Coronary Intervention Strategy: Insights From the STrategic Reperfusion Early After Myocardial Infarction (STREAM) Study.
    Shavadia J; Welsh R; Gershlick A; Zheng Y; Huber K; Halvorsen S; Steg PG; Van de Werf F; Armstrong PW
    J Am Heart Assoc; 2016 Jun; 5(6):. PubMed ID: 28525886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reperfusion strategies and outcomes of ST-segment elevation myocardial infarction patients in Canada: observations from the Global Registry of Acute Coronary Events (GRACE) and the Canadian Registry of Acute Coronary Events (CANRACE).
    Czarnecki A; Welsh RC; Yan RT; DeYoung JP; Gallo R; Rose B; Grondin FR; Kornder JM; Wong GC; Fox KA; Gore JM; Goodman SG; Yan AT; ;
    Can J Cardiol; 2012; 28(1):40-7. PubMed ID: 22129488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Impact of Out-of-Hours Presentation on Clinical Outcomes in ST-Elevation Myocardial Infarction.
    Biswas S; Brennan A; Duffy SJ; Andrianopoulos N; Chan W; Walton A; Noaman S; Shaw JA; Ajani A; Clark DJ; Freeman M; Hiew C; Oqueli E; Lefkovits J; Reid CM; Stub D
    Heart Lung Circ; 2020 Jun; 29(6):814-823. PubMed ID: 31262617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrinolysis use among patients requiring interhospital transfer for ST-segment elevation myocardial infarction care: a report from the US National Cardiovascular Data Registry.
    Vora AN; Holmes DN; Rokos I; Roe MT; Granger CB; French WJ; Antman E; Henry TD; Thomas L; Bates ER; Wang TY
    JAMA Intern Med; 2015 Feb; 175(2):207-15. PubMed ID: 25485876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic impact of non-compliance with guidelines-recommended times to reperfusion therapy in ST-elevation myocardial infarction. The FAST-MI 2010 registry.
    Puymirat E; Caudron J; Steg PG; Lemesle G; Cottin Y; Coste P; Schiele F; de Labriolle A; Bataille V; Ferrières J; Simon T; Danchin N;
    Eur Heart J Acute Cardiovasc Care; 2017 Feb; 6(1):26-33. PubMed ID: 26450784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reperfusion strategies and quality of care in 5339 patients age 80 years or older presenting with ST-elevation myocardial infarction: analysis from get with the guidelines-coronary artery disease.
    Medina HM; Cannon CP; Fonarow GC; Grau-Sepulveda MV; Hernandez AF; Frank Peacock W; Laskey W; Peterson ED; Schwamm L; Bhatt DL;
    Clin Cardiol; 2012 Oct; 35(10):632-40. PubMed ID: 22744844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced-dose fibrinolytic acceleration of ST-segment elevation myocardial infarction treatment coupled with urgent percutaneous coronary intervention compared to primary percutaneous coronary intervention alone results of the AMICO (Alliance for Myocardial Infarction Care Optimization) Registry.
    Denktas AE; Athar H; Henry TD; Larson DM; Simons M; Chan RS; Niles NW; Thiele H; Schuler G; Ahn C; Sdringola S; Anderson HV; McKay RG; Smalling RW
    JACC Cardiovasc Interv; 2008 Oct; 1(5):504-10. PubMed ID: 19463352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome up to one year following different reperfusion strategies in acute ST-segment elevation myocardial infarction: the Helsinki-Uusimaa Hospital District registry of ST-Elevation Acute Myocardial Infarction (HUS-STEMI).
    Viikilä J; Lilleberg J; Tierala I; Syvänne M; Kupari M; Salomaa V; Nieminen MS;
    Eur Heart J Acute Cardiovasc Care; 2013 Dec; 2(4):371-8. PubMed ID: 24338296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect on myocardial perfusion and clinical outcome of intracoronary nicorandil injection prior to percutaneous coronary intervention in ST-segment elevation myocardial infarction].
    Wang ZQ; Chen MX; Liu DL; Zheng WX; Cao XZ; Chen H; Huang MF; Luo ZR
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jan; 45(1):26-33. PubMed ID: 28100342
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacoinvasive Strategy Versus Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction in Patients ≥70 Years of Age.
    Auffret V; Laurin C; Leurent G; Didier R; Filippi E; Hacot JP; Zabalawi A; Rouault G; Saouli D; Druelles P; Coudert I; Boulanger B; Bot E; Treuil J; Bedossa M; Boulmier D; Loirat A; Sharobeem S; Guellec ML; Gilard M; Breton HL
    Am J Cardiol; 2020 Jan; 125(1):1-10. PubMed ID: 31685213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved Survival of Patients with ST-Segment Elevation Myocardial Infarction 3-6 Hours After Symptom Onset Is Associated with Inter-Hospital Transfer for Primary Percutaneous Coronary Intervention (PCI) at a Large Regional ST-Segment Elevation Myocardial Infarction (STEMI) Program vs. In-Hospital Thrombolysis in a Community Hospital.
    Zhao X; Yang X; Gao C; Chu Y; Yang L; Tian L; Li L
    Med Sci Monit; 2017 Feb; 23():1055-1063. PubMed ID: 28240997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.